美国四家大型医疗保健系统中重复粪便免疫化学与隐血试验筛查的模式与预测因素
本研究为多中心回顾性队列研究,纳入2010年1月至2011年12月完成基线粪便隐血试验(gFOBT)或粪便免疫化学试验(FIT)的50-71岁患者,分析其后3年重复筛查模式。在344,103名符合条件者中,46.6%持续筛查、43.4%不持续筛查、10%无重复筛查;各系统持续筛查比例从1%至54.3%不等,有外展和内展项目的系统比例较高,安全网系统采用机会性筛查比例最低。
要点
- 完成基线FOBT/FIT者中46.6%持续筛查、43.4%不持续筛查、10%无重复筛查。
- 各医疗系统持续筛查比例差异大,从1%到54.3%,无重复筛查从6.9%到42.8%。
- 有筛查外展和内展项目的系统持续筛查比例较高,机会性筛查的安全网系统最低。
核心结论
- 年度FOBT筛查的依从性在不同医疗保健系统间差异很大;组织化筛查项目的系统表现优于机会性筛查系统,但所有系统均需循证干预以提高结直肠癌筛查依从性。
研究设计与样本
- 多中心回顾性队列研究,纳入美国4家大型医疗保健系统中2010年1月至2011年12月完成基线gFOBT或FIT、年龄50-71岁且有至少3年随访的个体。
- 排除有结直肠癌史、基线检查前10年内结肠镜检查或5年内软式乙状结肠镜检查、或基线粪便检查阳性者。
主要发现
- 在344,103名符合条件患者中,46.6%持续筛查、43.4%不持续筛查、10%无重复筛查。
- 各系统持续筛查比例从1%至54.3%,无重复筛查比例从6.9%至42.8%。
- 有筛查外展和内展项目的系统持续筛查比例较高,采用机会性诊所筛查的安全网系统持续筛查最低。
- 持续筛查随年龄增长而增加,但在种族/族裔少数群体和合并症更多的患者中较少见。
关键数值与推荐
- 持续筛查定义为每15个月内重复FOBT;不持续筛查定义为随访期间至少重复一次但未达持续筛查标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Effectiveness of fecal occult blood test (FOBT) for colorectal cancer (CRC) screening depends on annual testing, but little is known about patterns of repeat stool-based screening within different settings. Our study's objective was to characterize screening patterns and identify factors associated with repeat screening among patients who completed an index guaiac FOBT (gFOBT) or fecal immunochemical test (FIT). METHODS: We performed a multi-center retrospective cohort study among people who completed a FOBT between January 2010 and December 2011 to characterize repeat screening patterns over the subsequent 3 years. We studied at 4 large health care delivery systems in the United States. Logistic regression analyses were used to identify factors associated with repeat screening patterns. We included individuals aged 50-71 years who completed an index FOBT and had at least 3 years of follow-up. We excluded people with a history of CRC, colonoscopy within 10 years or flexible sigmoidoscopy within 5 years before the index test, or positive index stool test. Consistent screening was defined as repeat FOBT within every 15 months and inconsistent screening as repeat testing at least once during follow-up but less than consistent screening. RESULTS: Among 959,857 eligible patients who completed an index FIT or gFOBT, 344,103 had three years of follow-up and met inclusion criteria. Of these, 46.6% had consistent screening, 43.4% inconsistent screening, and 10% had no repeat screening during follow-up. Screening patterns varied substantially across healthcare systems, with consistent screening proportions ranging from 1 to 54.3% and no repeat screening proportions ranging from 6.9 to 42.8%. Higher consistent screening proportions were observed in health systems with screening outreach and in-reach programs, whereas the safety-net health system, which uses opportunistic clinic-based screening, had the lowest consistent screening. Consistent screening increased with older age but was less common among racial/ethnic minorities and patients with more comorbidities. CONCLUSIONS: Adherence with annual FOBT screening is highly variable across healthcare delivery systems. Settings with more organized screening programs performed better than those with opportunistic screening, but evidence-based interventions are needed to improve CRC screening adherence in all settings.
引用
- Singal AG, Corley DA, Kamineni A, et al. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018. PMID: 29487413. doi:10.1038/s41395-018-0023-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。